Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

The co‐occurrence of cancer and heart failure (HF) represents a significant clinical drawback as each disease interferes with the treatment of the other. In addition to shared risk factors, a growing body of experimental and clinical evidence reveals numerous commonalities in the biology underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Rudolf A., Hulot, Jean‐Sébastien, Tocchetti, Carlo Gabriele, Aboumsallem, Joseph Pierre, Ameri, Pietro, Anker, Stefan D., Bauersachs, Johann, Bertero, Edoardo, Coats, Andrew J.S., Čelutkienė, Jelena, Chioncel, Ovidiu, Dodion, Pierre, Eschenhagen, Thomas, Farmakis, Dimitrios, Bayes‐Genis, Antoni, Jäger, Dirk, Jankowska, Ewa A., Kitsis, Richard N., Konety, Suma H., Larkin, James, Lehmann, Lorenz, Lenihan, Daniel J., Maack, Christoph, Moslehi, Javid J., Müller, Oliver J., Nowak‐Sliwinska, Patrycja, Piepoli, Massimo Francesco, Ponikowski, Piotr, Pudil, Radek, Rainer, Peter P., Ruschitzka, Frank, Sawyer, Douglas, Seferovic, Petar M., Suter, Thomas, Thum, Thomas, van der Meer, Peter, Van Laake, Linda W., von Haehling, Stephan, Heymans, Stephane, Lyon, Alexander R., Backs, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
Cardio‐oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894564/
https://www.ncbi.nlm.nih.gov/pubmed/33094495
http://dx.doi.org/10.1002/ejhf.2029

Ejemplares similares

Ejemplares similares